US › Healthcare

Telomir Pharmaceuticals, Inc. Common Stock (TELO)

US · Healthcare · Biotechnology

$1.12-0.88%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.7M

EPS

$-0.79

Key statistics

Market cap

$80.5M

Forward P/E

0.0

P/B

15.71

Book value

$0.14

EPS (TTM)

$-1.11

52-week high

$2.09

52-week low

$0.89

50-day MA

$1.17

200-day MA

$1.27

Beta

-0.25

Analyst view

with an average price target of $15.50.

Shareholding

Insiders

46.00%

Institutions

4.31%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.45%
BlackRock Inc	0.42%
Geode Capital Management, LLC	0.36%
Vanguard Fiduciary Trust Co	0.20%
State Street Corp	0.09%
Bank of New York Mellon Corp	0.07%
Northern Trust Corp	0.06%
Pensionmark Financial Group, LLC	0.05%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Telomir Pharmaceuticals, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.